mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al-Khatib, Patrick Tang, Mohammad R. Hasan, Joel A. Malek, Peter Coyle, Houssein H. Ayoub, Zaina Al Kanaani, Einas Al‐Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al‐Kuwari, Hamad Eid Al‐Romaihi, Mohamed H. Al‐Thani, Abdullatif Al Khal, Adeel A. Butt, Roberto Bertollini, Laith J. Abu‐Raddad
Topics & Concepts
MedicineConfidence intervalCoronavirus disease 2019 (COVID-19)PopulationPandemicInternal medicineRandomized controlled trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trialVaccine efficacyDiseaseImmunologyVaccinationInfectious disease (medical specialty)Environmental healthSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies